Drug and diet interactions: avoiding therapeutic paralysis

Area of Science:

• Pharmacology
• Drug Metabolism
• Biochemistry

Background:

• The cytochrome P450 (CYP) system, comprising over 500 genes, is crucial for drug metabolism.
• Understanding enzyme specificity, selectivity, genetics, and environmental factors is key to managing drug interactions.
• Information on antidepressant drug and diet interactions has become complex, impacting clinical use.

Purpose of the Study:

• To clarify the complex information regarding drug and diet interactions with antidepressants.
• To enhance the understanding of how these interactions affect antidepressant safety and efficacy.
• To provide a comprehensive overview of the cytochrome P450 system in relation to antidepressant medications.

Main Methods:

• Review of the cytochrome P450 (CYP) system, including enzyme families like CYP1A2, 2B6, 2C, 2D6, and 3A4.
• Analysis of antidepressant profiles as substrates, inhibitors, and inducers of CYP enzymes.
• Compilation of examples of beneficial and detrimental drug/drug and drug/diet interactions.

Main Results:

• Antidepressants act as substrates, inhibitors, or inducers of various CYP enzymes, influencing their own metabolism and that of other drugs.
• Specific drug and diet interactions can significantly alter antidepressant pharmacokinetics and pharmacodynamics.
• Genetics and nonpharmacologic factors also play a role in modulating these interactions.

Conclusions:

• Clear understanding of CYP-mediated interactions is essential for optimizing antidepressant therapy.
• Awareness of drug and diet interactions can prevent adverse events and improve treatment outcomes.
• This review provides a framework for clinicians to navigate complex antidepressant interactions safely and effectively.